The global cancer immunotherapy drug discovery outsourcing market size
is projected to reach USD 1.7Billion by 2025, according to a new report by
Grand View Research, Inc., rising at a CAGR of 13.5% during the forecast
period. Increasing prevalence of cancer and rising mortality associated with
cancer, along with growing development in the field of cancer immunotherapy,
are anticipated to stimulate the growth of the market.
In order to maintain pace with
increasing competition in the cancer therapeutics industry, pharmaceutical
companies spend 2.5% more than other high tech industries in the in-house
R&D. Hence, they are swiftly shifting towards outsourcing of drug discovery
in order to achieve lower in-house R&D costs.
Additionally, favorable tax credit
allows pharmaceutical companies to appropriately plan their global projects
with a reputed CRO and therefore, receive benefits and reduce problems
associated with taxation authorities or other bodies administering such
incentive programs.
Several new molecules for cancer
immunotherapy and new immunotherapeutic options, such as tumor infiltrating
lymphocytes, check point inhibitors immunomodulators, and CAR-T cell therapy,
have been introduced. Some are in the pipeline and are being tested for their
ability to provide better cancer treatment
Browse full research report on Cancer Immunotherapy Drug
Discovery Outsourcing Market: https://www.grandviewresearch.com/industry-analysis/cancer-immunotherapy-drug-discovery-outsourcing-market
Further Key Findings From the Report Suggest:
- Monoclonal antibodies emerged as the largest segment in 2017
because of increasing regulatory approvals and higher efficacy
- Target identification and validation accounted for the
largest share in the global market owing to higher costs incurred and
increased investments in new drug development
- North America dominated the market with the largest share in
2017. Rising incidence of cancer and increasing demand for novel
technologies are facilitating the dominance of the region during the
forecast period
- Some of the key players are Covance, Inc.; Explicyte; Aquila
BioMedical; Horizon Discovery Group PLC; Crown Bioscience, Inc.; Promega
Corporation; HD Biosciences Co., Ltd.; BPS Bioscience, Inc.; Genscript
Biotech Corporation; DiscoverX Corporation; Celentyx Ltd.; ImmunXperts SA;
Personalis, Inc.; STC Biologics; and Molecular Imaging, Inc. dominated the
cancer immunotherapy drug discovery outsourcing market.
Browse
request sample of this report by Grand View Research: https://www.grandviewresearch.com/industry-analysis/cancer-immunotherapy-drug-discovery-outsourcing-market/request/rs1
Grand View Research has segmented the global cancer immunotherapy
drug discovery outsourcing market based on drug type, service type, cancer
type, and region:
Cancer Immunotherapy Drug Discovery Outsourcing Drug Type
Outlook (Revenue, USD Million, 2014 - 2025)
- Monoclonal
Antibodies
- Immunomodulators
- Oncolytic
Viral Therapies and Cancer Vaccines
Cancer Immunotherapy Drug Discovery Outsourcing Service Type
Outlook (Revenue, USD Million, 2014 - 2025)
- Target
Identification and Validation
- Lead
Screening and Characterization
- Cell
Based Assays
Cancer Immunotherapy Drug Discovery Outsourcing Cancer Type
Outlook (Revenue, USD Million, 2014 - 2025)
- Lung
Cancer
- Breast
Cancer
- Colorectal
Cancer
- Melanoma
- Prostate
Cancer
- Head
and Neck Cancer
- Ovarian
Cancer
- Pancreatic
Cancer
Cancer Immunotherapy Drug Discovery Outsourcing Regional
Outlook (Revenue, USD Million, 2014 - 2025)
- North
America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Asia
Pacific
- India
- China
- Latin
America
- Brazil
- Mexico
- Middle
East & Africa
- South
Africa
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment